Google's AlphaGenome 2 Zooms In on the Cellular Roots of Disease

DeepMind's new DNA model better predicts how mutations affect different cells, potentially opening paths to treatment.

By Robert Hart

In 2026, as AI-driven genomics matures, Google's DeepMind has unveiled AlphaGenome 2, a next-generation DNA model that sharpens predictions of how genetic mutations influence cellular behavior. Building on its predecessor, the new model promises to accelerate the translation of genomic insights into targeted therapies.

A Sharper Lens on Cellular Mechanisms

AlphaGenome 2 improves upon earlier versions by more accurately modeling the effects of mutations across diverse cell types. This advance could help researchers identify disease mechanisms at the cellular level and design interventions that are more precisely tailored to individual patients.

Toward Clinical Impact

The model's enhanced predictive power may streamline drug discovery and enable earlier, more accurate diagnoses. As DeepMind continues to refine its AI tools for biology, AlphaGenome 2 stands as a significant step toward understanding—and ultimately treating—the cellular origins of disease.

via The Verge AI